Curanex Pharmaceuticals Inc (NASDAQ: CURX) Stock Information | RedChip
Image

ASK REDCHAT ANYTHING ABOUT CURANEX PHARMACEUTICALS INC

Curanex Pharmaceuticals Inc (NASDAQ: CURX)
Listen to this Section


$0.23
+0.0036 ( +1.62% ) 0.0K

Curanex Pharmaceuticals Inc is engaged in discovering, developing, and commercializing botanical drugs for treating unmet medical needs in patients with inflammatory disease. Its compound, Phyto-N, is in preclinical research for six indications: ulcerative colitis, atopic dermatitis, COVID-19, type 2 diabetes, nonalcoholic fatty liver disease (NAFLD) and gout.

Market Data


Open $0.23
Previous Close $0.22
Volume 0.0K
Market Cap $6.32M
Day Range $0.22 - $0.22
52 Week Range $0.21 - $9.18
Shares Outstanding 28.36M
Change % +1.62%
Net Change ▲ 0.0036
Insider Ownership N/A
Exchange NASDAQ
Sector
IndustryPHARMACEUTICAL PREPARATIONS
IPO Year2025
CountryUnited States
UnderwriterDominari Securities, Revere Securities, Pacific Century Securities, more

Insider Ownership Transactions

Total Amount Purchased: 0.00

Date Type Amount Purchased Purchaser
No records found.

SEC Filings


Form Type Description Pages Date
8-k 8K-related 12 Nov 06, 2025
8-k 8K-related 12 Sep 29, 2025
8-k 8K-related 14 Sep 12, 2025
10-q Quarterly Reports 52 Sep 09, 2025
3 Insider transactions 1 Sep 02, 2025
3 Insider transactions 1 Sep 02, 2025
3 Insider transactions 1 Sep 02, 2025
3 Insider transactions 1 Sep 02, 2025
3 Insider transactions 1 Sep 02, 2025
3 Insider transactions 1 Sep 02, 2025

Latest News